A Phase II Study of Sirolimus in Renal Transplant Patients Diagnosed With New or Recurrent Squamous Cell Skin Carcinoma Currently on Calcineurin-based Immunosuppression.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Tacrolimus
- Indications Renal transplant rejection; Skin cancer
- Focus Therapeutic Use
- 15 Aug 2013 Planned number of patients changed from 106 to 43 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Mar 2013 Planned initiation date changed from 1 Jan 2013 to 1 Mar 2013 as reported by ClinicalTrials.gov.